Did the major clinical trials of statins affect prescribing behaviour?

CMAJ. Canadian Medical Association Journal

Volumn 164, Issue 12, 2001, Pages 1695-1696

  Mamdani, M M ^a   Tu, J V ^a  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; SIMVASTATIN;

ARTICLE; CANADA; CLINICAL TRIAL; DRUG COST; DRUG MARKETING; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL PRACTICE; PHYSICIAN ATTITUDE; PRESCRIPTION;

EID: 0034920434     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Time trend analysis and variations in prescribing lipid lowering drugs in general practice
2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
4. The effect of pravastatin on coronary events after myocardial infarctions in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators
5. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
6. Therapeutic-class wars - Drug promotion in a competitive marketplace
7. Are drugs within a class interchangeable?